Latest filing published 23 Mar 2026 for iBio, Inc., €44k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -65.4%Entry US$2.08 · Close 23 Oct 2026 US$0.72
- -8.8%Entry US$2.73 · Close at T+365 US$2.49
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Felipe Duran: trading record in brief
Felipe Duran is a declared insider of iBio, Inc., with filings sourced from SEC (Form 4). Between 31 March 2023 and 19 March 2026, the trades on record add up to 3 filings.
On the market, this insider has only ever bought: 2 purchases, €68k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 1 share grant. In 2026 alone, the filings show 1 purchase and no sales.
The latest filing, published on 23 March 2026, reports an open-market purchase of €44k in iBio, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Felipe Duran
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 24,835 shares@ US$2.018664.3% of flowCommon StockSEC:0001104659-26-033028:0Canonical exit: 17 Jun 2026 (T+90)
- 9,191 shares@ US$2.7235.7% of flowCommon StockSEC:0001104659-25-003064:0Canonical exit: 10 Apr 2025 (T+90)
- 37,500 shares0Common StockSEC:0001104659-23-040818:0
3 of 3 declarations